Moventia and the Josep Carreras Foundation against Leukaemia, a non-profit organisation aimed at fighting leukaemia, signed the renewal of a partnership agreement in June that was first signed in 2023.
The agreement seeks to maintain their partnership on the Together, we move for oncohaematology patients project, the purpose of which is to meet part of the travel costs incurred by bone marrow donors. In this regard, the journeys made entirely voluntarily and altruistically by the people contacted by the Spanish Register of Bone Marrow Donors (REDMO) of the Josep Carreras Foundation against Leukaemia – journeys that enable the donation to take place — will continue to be paid for by Moventia.
Reapproval of the funds for 2024 was made possible by the good results obtained in 2023, in which Moventia paid for the travel costs of 272 bone marrow donors. The foundation coordinated almost 400 bone marrow donations, which is a 24% increase on 2022. Thanks to these efforts, 947 patients from around the world received another chance at life.
Toni García, Head of the Josep Carreras Foundation against Leukaemia, welcomed the agreement and said “Renewing this partnership is great news for the whole team at the foundation. It lets us continue supporting projects tied to our vision as a foundation. Moventia pays for the transport costs of those bone marrow donors registered with REDMO who altruistically give another chance to patients who need it. Such generosity is a key value of both the donors themselves and Moventia by funding this service for us”.
Sílvia Martí, Corporate Vice-President for Internal Communication at the multinational mobility specialist, said “Maintaining our relationship and agreement with the Josep Carreras Foundation, an organisation that has a long history in the fight against leukaemia and blood diseases through all sorts of projects since 1988, is a milestone that we are hugely proud of as a company”. “The commitment from Moventia to the society that surrounds us is inherent, which is why we are once again reaffirming our commitment to the foundation and joining the unstoppable fight against leukaemia”, she added.
About leukaemia in Spain:
According to the Spanish Association against Cancer, 6,074 people were diagnosed with leukaemia in Spain in 2023. The number of cases in men was higher than in women (3,487 and 2,587 estimated new cases, respectively). Furthermore, according to data from the Josep Carreras Foundation, 300 new cases of child leukaemia are diagnosed in Spain every year, of which most are acute lymphoblastic leukaemia (ALL).
The likelihood of developing leukaemia increases with age, with the highest number of cases occurring in the population over 65 years of age. Although most leukaemia patients are adults, leukaemia is the most common neoplasia in children (30% of paediatric cancers).